Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19912580rdf:typepubmed:Citationlld:pubmed
pubmed-article:19912580lifeskim:mentionsumls-concept:C0025344lld:lifeskim
pubmed-article:19912580lifeskim:mentionsumls-concept:C0005841lld:lifeskim
pubmed-article:19912580lifeskim:mentionsumls-concept:C0033105lld:lifeskim
pubmed-article:19912580lifeskim:mentionsumls-concept:C2347804lld:lifeskim
pubmed-article:19912580lifeskim:mentionsumls-concept:C1561960lld:lifeskim
pubmed-article:19912580lifeskim:mentionsumls-concept:C1948053lld:lifeskim
pubmed-article:19912580pubmed:issue3lld:pubmed
pubmed-article:19912580pubmed:dateCreated2010-6-11lld:pubmed
pubmed-article:19912580pubmed:abstractTextTransfusion practice is reported to differ considerably between countries. Comparisons often rely on transfusion rates, incidence - or prevalence rates. In this paper, the one-year period prevalence rate (1-YPPR) of transfusion of red cells (RBC) is presented. Transfusion data, demographic data and patient data were retrospectively combined to calculate sex and diagnosis specific and age standardized 1-YPPR s of RBC transfusion for the complete population in a Danish county. During the calendar year of 2006, 4427 patients received RBC transfusion in Funen County. The crude 1-YPPR of RBC transfusion was 9.2/1000 citizens. Most of the transfused patients had a main diagnosis of neoplasm (22% of recipients), diseases of the circulatory system (15%), the digestive system (15%), injuries (13%) and diseases of the blood (8%). Age standardization reversed the relation between sex specific 1-YPPRs, yielding a statistically significantly higher 1-YPPR in males (6.8/1000) vs. females (6.3/1000). The method for calculating a diagnosis specific 1-YPPR of transfusion of RBC is presented and proposed as an option for comparison of transfusion practice with other transfusion centres. The crude and the diagnosis specific 1-YPPR s are found to increase with age. Thus, age standardization of crude prevalence rates is necessary for meaningful comparisons between populations.lld:pubmed
pubmed-article:19912580pubmed:languageenglld:pubmed
pubmed-article:19912580pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19912580pubmed:citationSubsetIMlld:pubmed
pubmed-article:19912580pubmed:statusMEDLINElld:pubmed
pubmed-article:19912580pubmed:monthJunlld:pubmed
pubmed-article:19912580pubmed:issn1365-3148lld:pubmed
pubmed-article:19912580pubmed:authorpubmed-author:TitlestadKKlld:pubmed
pubmed-article:19912580pubmed:authorpubmed-author:GeorgsenJJlld:pubmed
pubmed-article:19912580pubmed:authorpubmed-author:MadsenJ TJTlld:pubmed
pubmed-article:19912580pubmed:authorpubmed-author:Kimper-KarlM...lld:pubmed
pubmed-article:19912580pubmed:authorpubmed-author:SprogøeUUlld:pubmed
pubmed-article:19912580pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19912580pubmed:volume20lld:pubmed
pubmed-article:19912580pubmed:ownerNLMlld:pubmed
pubmed-article:19912580pubmed:authorsCompleteYlld:pubmed
pubmed-article:19912580pubmed:pagination191-5lld:pubmed
pubmed-article:19912580pubmed:meshHeadingpubmed-meshheading:19912580...lld:pubmed
pubmed-article:19912580pubmed:meshHeadingpubmed-meshheading:19912580...lld:pubmed
pubmed-article:19912580pubmed:meshHeadingpubmed-meshheading:19912580...lld:pubmed
pubmed-article:19912580pubmed:meshHeadingpubmed-meshheading:19912580...lld:pubmed
pubmed-article:19912580pubmed:meshHeadingpubmed-meshheading:19912580...lld:pubmed
pubmed-article:19912580pubmed:meshHeadingpubmed-meshheading:19912580...lld:pubmed
pubmed-article:19912580pubmed:meshHeadingpubmed-meshheading:19912580...lld:pubmed
pubmed-article:19912580pubmed:meshHeadingpubmed-meshheading:19912580...lld:pubmed
pubmed-article:19912580pubmed:meshHeadingpubmed-meshheading:19912580...lld:pubmed
pubmed-article:19912580pubmed:meshHeadingpubmed-meshheading:19912580...lld:pubmed
pubmed-article:19912580pubmed:meshHeadingpubmed-meshheading:19912580...lld:pubmed
pubmed-article:19912580pubmed:meshHeadingpubmed-meshheading:19912580...lld:pubmed
pubmed-article:19912580pubmed:meshHeadingpubmed-meshheading:19912580...lld:pubmed
pubmed-article:19912580pubmed:meshHeadingpubmed-meshheading:19912580...lld:pubmed
pubmed-article:19912580pubmed:meshHeadingpubmed-meshheading:19912580...lld:pubmed
pubmed-article:19912580pubmed:meshHeadingpubmed-meshheading:19912580...lld:pubmed
pubmed-article:19912580pubmed:meshHeadingpubmed-meshheading:19912580...lld:pubmed
pubmed-article:19912580pubmed:year2010lld:pubmed
pubmed-article:19912580pubmed:articleTitleOne-year period prevalence of blood transfusion.lld:pubmed
pubmed-article:19912580pubmed:affiliationDepartment of Clinical Immunology, Odense University Hospital, Odense C, Denmark. jtmadsen@dadlnet.dklld:pubmed
pubmed-article:19912580pubmed:publicationTypeJournal Articlelld:pubmed